Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D2 production

International Archives of Allergy and Immunology

Volumn 147, Issue 4, 2008, Pages 338-343

  Butterfield, Joseph H ^a   Weiler, Catherine R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Mast cell activation; Mastocytosis; Prostaglandin D2

Indexed keywords

11 EPIPROSTAGLANDIN F2 ALPHA; ACETYLSALICYLIC ACID; ADRENALIN; AMFEBUTAMONE; CALCITONIN; CETIRIZINE; CORTICOSTEROID DERIVATIVE; DESLORATADINE; DIPHENHYDRAMINE; DOXEPIN; ESCITALOPRAM; FAMOTIDINE; FERROUS SULFATE; GLIPIZIDE; HISTAMINE; IBUPROFEN; LORATADINE; MONTELUKAST; N METHYLHISTAMINE; PREDNISONE; PROSTAGLANDIN D2; RABEPRAZOLE; RANITIDINE; TRYPTASE; VALSARTAN;

ADULT; ANAMNESIS; ARTICLE; BEDTIME DOSAGE; BONE MARROW BIOPSY; CARDIOVASCULAR DISEASE; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MECHANISM; EOSINOPHILIA; FEMALE; GASTRITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IRON DEFICIENCY ANEMIA; LABORATORY TEST; MALE; MAST CELL ACTIVATION DISORDER; MASTOCYTOSIS; MATURITY ONSET DIABETES MELLITUS; MEDIATOR RELEASE; OBSESSIVE COMPULSIVE DISORDER; PERIORBITAL EDEMA; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROSTAGLANDIN URINE LEVEL; PROTEIN BLOOD LEVEL; STOMACH ULCER; TREATMENT OUTCOME; URINARY EXCRETION;

ADULT; ANAPHYLAXIS; ASPIRIN; FEMALE; HISTAMINE RELEASE; HUMANS; MALE; MAST CELLS; MASTOCYTOSIS; MIDDLE AGED; PROSTAGLANDIN D2; TRYPTASES;

EID: 56549084041     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000144042     Document Type: Article

References (35)

1. Roberts LJ II: Carcinoid syndrome and disorders of systemic mast-cell activation including systemic mastocytosis. Endocrinol Metab Clin North Am 1988;17:415-436.
2. Sheffer AL, Austen KF: Exercise-induced anaphylaxis. J Allergy Clin Immunol 1980;66:106-111.
3. Sheffer AL, Tong AK, Murphy GF, Lewis RA, McFadden ER Jr, Austen KF: Exercise-induced anaphylaxis: a serious form of physical allergy associated with mast cell degranulation. J Allergy Clin Immunol 1985;75:479-484.
4. Lewis J, Lieberman P, Treadwell G, Erffmeyer J: Exercise-induced urticaria, angioedema, and anaphylactoid episodes. J Allergy Clin Immunol 1981;68:432-437.
5. Novey HS, Fairshter RD, Salness K, Simon RA, Curd JG: Postprandial exercise-induced anaphylaxis. J Allergy Clin Immunol 1983;71:498-504.
6. Buchbinder EM, Bloch KJ, Moss J, Guiney TE: Food-dependent, exercise-induced anaphylaxis. JAMA 1983;250:2973-2974.
7. Wiggins CA, Dykewicz MS, Patterson R: Idiopathic anaphylaxis: classification, evaluation, and treatment of 123 patients. J Allergy Clin Immunol 1988;82:849-855.
8. Sonin L, Patterson R: Metabisulfite challenge in patients with idiopathic anaphylaxis. J Allergy Clin Immunol 1985;75:67-69.
9. Wong S, Yarnold PR, Yango C, Patterson R, Harris KE: Outcome of prophylactic therapy for idiopathic anaphylaxis. Ann Intern Med 1991;114:133-136.
10. Yocum MW, Butterfield JH, Klein JS, Volcheck GW, Schroeder DR, Silverstein MD: Epidemiology of anaphylaxis in Olmsted County: a population-based study. J Allergy Clin Immunol 1999;104:452-456.
11. Erffmeyer JE, Siegle RL, Lieberman P: Allergy grand rounds: anaphylactoid reactions to radiocontrast material. J Allergy Clin Immunol 1985;75:401-410.
12. Ring J, Arroyave CM, Frizler MJ, Tan EM: In vitro histamine and serotonin release by radiographic contrast media (RCM): complement-dependent and -independent release reaction and changes in ultrastructure of human blood cells. Clin Exp Immunol 1978;32:105-118.
13. Lasser EC, Lang JH, Lyon SG, Hamblin AE: Changes in complement and coagulation factors in a patient suffering a severe anaphylactoid reaction to injected contrast material: some considerations of pathogenesis. Invest Radiol 1980;15(suppl 6):S6-S12.
14. Zeman RK: Disseminated intravascular coagulation following intravenous pyelography. Invest Radiol 1977;12:203-204.
15. Rosenfield AT, Littner MR, Ulreich S, Farmer WC, Putman CE: Respiratory effects of excretory urography: a preliminary report. Invest Radiol 1977;12:295-298.
16. Littner MR, Rosenfield AT, Ulreich S, Putman CE: Evaluation of bronchospasm during excretory urography. Radiology 1977;124:17-21.
17. Lasser EC: Metabolic basis of contrast material toxicity: status 1971. Hickey lecture, 1971. Am J Roentgenol Radium Ther Nucl Med 1971;113:415-422.
18. Lasser EC, Lang JH: Contrast-protein interactions. Invest Radiol 1970;5:446-457.
19. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T: Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987;316:1622-1626.
20. Vinuya RZ, Simon MR, Schwartz LB: Elevated serum tryptase levels in a patient with protracted anaphylaxis. Ann Allergy 1994;73:232-234.
21. Douglas DM, Sukenick E, Andrade WP, Brown JS: Biphasic systemic anaphylaxis: an inpatient and outpatient study. J Allergy Clin Immunol 1994;93:977-985.
22. Wong S, Dykewicz MS, Patterson R: Idiopathic anaphylaxis: a clinical summary of 175 patients. Arch Intern Med 1990;150:1323-1328.
23. Ditto AM, Krasnick J, Greenberger PA, Kelly KJ, McGrath K, Patterson R: Pediatric idiopathic anaphylaxis: experience with 22 patients. J Allergy Clin Immunol 1997;100:320-326.
24. Shaffer HC, Parsons DJ, Peden DB, Morrell D: Recurrent syncope and anaphylaxis as presentation of systemic mastocytosis in a pediatric patient: case report and literature review. J Am Acad Dermatol 2006;54(suppl 5):S210-S213.
25. Lin RY, Schwartz LB, Curry A, Pesola GR, Knight RJ, Lee HS, et al: Histamine and tryptase levels in patients with acute allergic reactions: an emergency department-based study. J Allergy Clin Immunol 2000;106:65-71.
26. van der Donk EM, Blok W, Kok PT, Bruijnzeel PL: Leukotriene C 4 formation by enriched human basophil preparations from normal and asthmatic subjects. Prostaglandins Leukot Essent Fatty Acids 1991;44:11-17.
27. 2 in man. Prostaglandins 1984;28:755-767.
28. 2 in human skin. Clin Allergy 1988;18:619-627.
29. 4. Thorax 1997;52:513-518.
30. 2 in vivo. Thorax 2004;59:453-455.
31. 2 and histamine release in cold urticaria. J Allergy Clin Immunol 1986;78:458-461.
32. 2 and histamine in a case of localized heat urticaria, and effect of treatments. Br J Dermatol 1986;115:721-728.
33. 2 in patients with systemic mastocytosis. N Engl J Med 1980;303:1400-1404.
34. 2): a unique biologically active prostaglandin produced enzymatically in vivo in humans. Proc Natl Acad Sci USA 1985;82:6030-6034.
35. Roberts LJ II, Turk JW, Oates JA: Shock syndrome associated with mastocytosis: pharmacologic reversal of the acute episode and therapeutic prevention of recurrent attacks. Adv Shock Res 1982;8:145-152.